Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(11%)
Results Posted
40%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_3
1
11%
Ph not_applicable
6
67%
Ph phase_4
2
22%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Terminated1
Not yet recruiting1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (11.1%)
Phase 42 (22.2%)
N/A6 (66.7%)

Trials by Status

terminated111%
not_yet_recruiting111%
recruiting111%
unknown111%
completed556%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9